United Imaging Healthcare Reports Strong 2024 Financials and AI Innovations
United Imaging Healthcare has released its 2024 annual report, showcasing robust financial performance and significant advancements in AI-powered medical devices.
Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
United Imaging Healthcare has released its 2024 annual report, showcasing robust financial performance and significant advancements in AI-powered medical devices.
C the Signs, an AI-led triage platform, has improved early cancer detection rates by 20% across NHS GP practices, while reducing unnecessary urgent referrals by over 61,000 patients, announced in a press release.
House Rx has announced a new AI capability that streamlines the prior authorization process for specialty medications, achieving a 92% first-pass approval rate.
Gestalt Diagnostics has raised $7.5 million in Series A funding to expand its AI-powered PathFlow platform, with the round led by Cowles Ventures and other investors.
Belong.Life has partnered with Equiva to integrate AI mentors into healthcare platforms, aiming to enhance patient support and outcomes.
O'Shaughnessy Ventures has awarded a $100,000 fellowship to AI researcher Miguel Solano to advance projects in drug discovery and clean energy.
Symphony Robotics has appointed Dr. Neil A. Martin as Chief Medical Officer to lead the development of its MRI-steerable micro-robotics for glioblastoma treatment.
Precision for Medicine and PathAI have announced a strategic collaboration to integrate AI-based technologies into clinical trial and biospecimen operations, enhancing biomarker discovery and pathology tools.
Clarius Mobile Health has launched Clarius Prostate AI, an FDA-cleared tool for handheld ultrasound scanners, enabling quick prostate volume assessments.
ApolloMD has announced a partnership with Cleo Health to implement AI technology in emergency medicine, aiming to improve patient care and physician satisfaction.
Abu Dhabi's Department of Health has led a roundtable to develop AI governance principles for healthcare, focusing on ethics and patient safety.
Araceli Biosciences has completed a $11.2 million seed funding round to enhance its high-content imaging and AI-powered analysis capabilities.
Simplex Quantum and the University of Tokyo have introduced a new AI system for heart failure monitoring, achieving 91.6% accuracy in severity assessment, as announced in a press release.
Neighborhood Healthcare has integrated Nabla's ambient AI technology to improve clinician support and patient experience, following a successful pilot program.
Glytec has appointed Coy Gupta as Chief Technology Officer to lead its AI and innovation strategy, enhancing its diabetes management platform.
OMRON Healthcare has announced the donation of 4,000 blood pressure monitors equipped with AI-based Intellisense AFib technology to May Measurement Month, enhancing atrial fibrillation screening.
Flagship Pioneering has launched Etiome, a company focused on preemptive healthcare using its AI-powered Temporal Biodynamics platform. The initiative aims to detect and halt disease progression early.
Infinitus Systems, Inc. has introduced the first voice AI agents designed for healthcare, ensuring trust and compliance in patient-provider interactions.
Former Nike VP Bert Hoyt has joined Decentralized Biotechnology Intelligence Holding Group Inc. (dBio) as a Board Advisor to drive innovation in sports and health tech.
Mayo Clinic has licensed MammoScreen, an AI-based breast cancer screening software developed by Therapixel, for use in its radiology departments.